ISRCTN ISRCTN10092153
DOI https://doi.org/10.1186/ISRCTN10092153
Secondary identifying numbers CV 16-63
Submission date
12/10/2016
Registration date
28/10/2016
Last edited
22/01/2018
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Presbyopia is a condition associated with aging in which the eye’s ability to focus on near objects gradually becomes more difficult. Multifocal contact lenses can be used to help people with presbyopia to see objects both in the distance and up close; however, how well these contact lenses perform depends on the wearer’s prescription, their activities and lighting conditions. The aim of this study is to measure and compare the visual performance and visual satisfaction achieved with two pairs of multifocal contact lenses which are designed to correct distance, intermediate and near vision.

Who can participate?
Adults who are at least 40 and who have healthy eyes other than for needing a near-vision correction

What does the study involve?
Participants' eyes are examined by the investigator and they are fitted with a pair of the first type of multifocal contact lenses. They are provided with a supply of these lenses to be worn on a daily disposable basis (wearing one pair each day and discarding it at the end of the day) and asked to return after a period of 7 to 10 days. At this time they are asked to complete a short questionnaire about the lenses and then the investigator measures their vision with the lenses. They are asked to read letters of different sizes on both a computer screen and on smaller electronic tablets under bright, normal and dim lighting conditions. They then remove the lenses and their eyes are once again examined by the investigator before they are fitted with a pair of the second type of multifocal lenses. They are provided with a supply of these lenses to be worn on a daily disposable basis to return after a further period of 7 to 10 days. At this time they are asked to complete a short questionnaire about the lenses and then the investigator measures their vision with these lenses. They then remove the lenses and their eyes are once again examined by the investigator. All study participants undergo the same series of vision tests and tasks.

What are the possible benefits and risks of participating?
Participants may not directly benefit from taking part in this study, but the results of the study may contribute towards the development of new, perhaps more successful, contact lenses. The examination and assessments of the front part of the eye are at no cost to participants and can be considered beneficial by documenting their current health status. All contact lenses have the potential of causing serious injury to the eye. Due to the nature and duration of the study the risks of participating in this study are considered to be similar to those of normal contact lens wear. It is possible that the following problems may occur with the use of contact lenses: eyes stinging, burning, itching (irritation) or other eye pain; feeling that something is in the eye such as a foreign body or scratched area; excessive watering (tearing) of the eye; unusual eye secretions; redness of the eye; reduced sharpness of vision (poor visual acuity); blurred vision, rainbows, or halos around objects; sensitivity to light (photophobia); or dry eyes. In rare instances, corneal ulcers (open sores on the eye), scarring, the growth of blood vessels into the cornea, temporary or permanently decreased vision, iritis (inflammation of the iris) and infections of the eye requiring treatment might occur.

Where is the study run from?
Ocular Technology Group - International (UK)

When is the study starting and how long is it expected to run for?
October 2016 to January 2017

Who is funding the study?
CooperVision Inc. (USA)

Who is the main contact?
Ms Trisha Patel

Contact information

Ms Trisha Patel
Public

66 Buckingham Gate
London
SW1E 6AU
United Kingdom

Study information

Study designSingle-arm prospective randomized cross-over study with investigator and participant masking
Primary study designInterventional
Secondary study designRandomised cross over trial
Study setting(s)Other
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a participant information sheet
Scientific titleVisual satisfaction with a multifocal lens design combination: a randomized cross-over study
Study objectivesNo information is currently available regarding the relative visual satisfaction and acceptance of the multifocal contact lens combinations to be tested when they are worn by individuals conducting everyday activities. Therefore, the study will be an exploratory investigation to further the understanding of the effect of the optical design and fitting approach of multifocal contact lenses on visual performance and acceptance with a view to selecting the optimal lens designs for early, intermediate and advanced presbyopes. There is no formal hypothesis for this trial.
Ethics approval(s)National Research Ethics Committee - South West - Exeter, 22/09/2016, ref: 16/SW/0279
Health condition(s) or problem(s) studiedPresbyopia
InterventionThe two types of multifocal contact lenses to be tested differ in their power profiles across the lens (zones for distance, intermediate and near correction of vision). Participants' eyes will be examined by the investigator and they will be provided with a supply of the first type of lenses to be worn on a daily disposable basis (wearing one pair each day and discarding it at the end of the day) and asked to return after a period of 7 to 10 days. At this time they will be asked to complete a short questionnaire about the lenses and then the investigator will measure their vision with the lenses. They will be asked to read letters of different sizes on both a computer screen and on smaller electronic tablets under bright, normal and dim lighting conditions. They will then remove the lenses and their eyes will once again be examined by the investigator before they are fitted with a pair of the second type of multifocal lenses. They will be provided with a supply of these lenses to be worn on a daily disposable basis to return after a further period of 7 to 10 days. At this time they will be asked to complete a short questionnaire about the lenses and then the investigator will measure their vision with these lenses. They will then remove the lenses and their eyes will once again be examined by the investigator before they are discharged from the study. All study participants will undergo the same series of vision tests and tasks.
Intervention typeOther
Primary outcome measureSubjective assessment of overall visual satisfaction, measured using a 100-point Visual Analog Scale (VAS) at the dispensing visit and follow-up visit for each of the lens types
Secondary outcome measuresBinocular visual performance, measured using high and low contrast LogMAR visual acuity charts at distance (4m), intermediate (67cm) and near (40cm) under high, medium and low levels of illumination, at the follow-up visit for each lens type
Overall study start date03/10/2016
Completion date22/02/2017

Eligibility

Participant type(s)Other
Age groupAdult
SexBoth
Target number of participantsA total of 40 participants will be enrolled
Key inclusion criteria1. At least 40 years old
2. Have read and understood the Participant Information Sheet
3. Have read, signed and dated the Informed Consent
4. Best corrected visual acuity of at least 20/25 in each eye
5. Have normal eyes with the exception of the need for visual correction
6. Current multifocal contact lens wearer
7. Spectacle refraction:
8. Distance: Sphere: -6.00D to + 4.00D, Astigmatism: 0.00D to -0.75D
9. Near Addition: +0.75D to +2.50D in three groups:
9.1. Emerging presbyopes: +0.75D to +1.25D
9.2. Established presbyopes:+1.50D and +1.75D
9.3. Advanced presbyopes: +2.00D to +2.50D
10. Be willing and able to adhere to the instructions set in the clinical protocol and maintain the appointment schedule
Key exclusion criteria1. Ocular anterior segment infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear
2. Use of systemic or ocular medications for which contact lens wear could be contraindicates as determined by the investigator
3. Monocular participants (only one eye with functional vision) or participants fit with only one lens
4. Any moderate or severe ocular condition observed during the slit-lamp examination at the enrolment visit
5. History of herpetic keratitis, ocular surgery or irregular cornea
6. Known pregnancy or lactation during the study period
7. Enrolment of the investigator or his/her staff, family members of the investigator, family members of the investigator’s staff, or individuals living in the households of these individuals
Date of first enrolment03/10/2016
Date of final enrolment31/12/2016

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Ocular Technology Group - International
SW1E 6AU
United Kingdom

Sponsor information

CooperVision Inc.
Industry

5870 Stoneridge Drive
Suite 1
Pleasanton
94588
United States of America

Funders

Funder type

Industry

CooperVision Inc.

No information available

Results and Publications

Intention to publish date31/01/2018
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryStored in repository
Publication and dissemination planTo be confirmed at a later date
IPD sharing planParticipants are referred to by participant number and not name; however, initials and date of birth will be recorded on the study documents.
A web based data entry system is used to collect participant data. It is built around Entrypoint i4 (Phoenix Software International) which stores all data in a secure SQL database. Access is controlled by defining security profiles and associating each user with the appropriate profile. Every user must have a registered account with 
a unique name and password and a specified level of system authority. The software allows the generation of accurate and complete copies of records in both human readable and electronic form suitable for inspection, review, and analysis. Users with the right level of authority can view and print the data and reports of files. A dedicated server is used and the hardware is firewalled and is protected by antivirus software. The database is backed up daily and encrypted onto an external device. This encrypted data is then mirrored remotely to an external offsite location.
Participants are advised that their data are being collected for research purposes and may be used for additional scientific research, educational purposes and publications. Information will be encoded in order to safeguard their confidentiality, and if the results of the research are published or used in reports of the study or for scientific presentations, their identity will remain confidential. Any study information which is transferred to the Sponsor will be fully anonymised and neither the participant’s identity or date of birth will be transferred; they will only be referred to by their participant number.
Participants are provided with all of the information relating to their confidentiality and how their data may be used in the Participant Information Sheet and provide written consent for this.

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
HRA research summary 28/06/2023 No No

Editorial Notes

22/01/2018: The overall trial end date was changed from 31/01/2017 to 22/02/2017.